| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.01uM, 1-Naphthalenecarboxamide, 6-[(2-amino-4-pyrimidinyl)oxy]-N-[4-fluoro-3-(trifluoromethyl)phenyl]-, VEGFR-2 (FLK-1/KDR) Inhibitors targeting KDR (Novartis, 16071550) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/16071550 |
| Similar Terms | |
| Downloads & Tools |
3 genes differentially expressed following the BE-33-IM71_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| POLR2L | polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa | 0.422717 |
| ARF6 | ADP-ribosylation factor 6 | 0.217313 |
| Symbol | Name | Standardized Value |
|---|---|---|
| DAZAP2 | DAZ associated protein 2 | -0.422717 |